Supernus Pharmaceuticals (S49) Stock Forecast & Price Target

Compare

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

S49 Analyst Ratings

Currently, no data available

Based on NaN analysts giving stock ratings to

Supernus

Pharmaceuticals

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

S49 Stock 12 Month Forecast

There Are No Analyst Ratings for CH:S49 In The Last 3 Months.

Highest Price Target―

Average Price Target―

Lowest Price Target―

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

S49 Financial Forecast

S49 Earnings Forecast

Next quarter’s earnings estimate for S49 is $0.32 with a range of $0.20 to $0.42. The previous quarter’s EPS was $0.81. S49 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year S49 has Preformed in-line its overall industry.

S49 Sales Forecast

Next quarter’s sales forecast for S49 is $158.13M with a range of $149.49M to $163.97M. The previous quarter’s sales results were $155.40M. S49 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year S49 has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts

Pavan Patel

Bank of America Securities

Not Ranked

Bank of America Securities

CHF52.32

Buy

―

Reiterated

10/31/25

Supernus initiated with a Buy at BofASupernus initiated with a Buy at BofA

Stacy Ku

TD Cowen

CHF36.22→CHF48.29

Buy

―

Reiterated

10/23/25

Supernus Pharmaceuticals (SUPN) Gets a Buy from TD Cowen

Bryce Generon

TR | OpenAI - 4o

CHF41.85→CHF45.88

Buy

―

Reiterated

10/23/25

AI Generated ArticleAI Generated Article

David Amsellem

Piper Sandler

CHF52.32

Buy

―

Reiterated

10/17/25

Piper Sandler Remains a Buy on Supernus Pharmaceuticals (SUPN)

Kristen Kluska

Cantor Fitzgerald

CHF33.8→CHF50.71

Buy

―

Reiterated

09/29/25

Cantor Fitzgerald Sticks to Their Buy Rating for Supernus Pharmaceuticals (SUPN)

Annabel Samimy

Stifel Nicolaus

CHF30.59→CHF34.61

Hold

―

Reiterated

08/06/25

Supernus Pharmaceuticals (SUPN) Gets a Hold from Stifel Nicolaus

Andrew Tsai

Jefferies

CHF32.19

Buy

―

Reiterated

03/12/25

Promising Growth Prospects for Supernus Pharmaceuticals: Buy Rating Driven by Qelbree and Onapgo Market Opportunities

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Pavan Patel

Bank of America Securities

Not Ranked

Bank of America Securities

CHF52.32

Buy

―

Reiterated

10/31/25

Supernus initiated with a Buy at BofASupernus initiated with a Buy at BofA

Stacy Ku

TD Cowen

CHF36.22→CHF48.29

Buy

―

Reiterated

10/23/25

Supernus Pharmaceuticals (SUPN) Gets a Buy from TD Cowen

Bryce Generon

TR | OpenAI - 4o

CHF41.85→CHF45.88

Buy

―

Reiterated

10/23/25

AI Generated ArticleAI Generated Article

David Amsellem

Piper Sandler

CHF52.32

Buy

―

Reiterated

10/17/25

Piper Sandler Remains a Buy on Supernus Pharmaceuticals (SUPN)

Kristen Kluska

Cantor Fitzgerald

CHF33.8→CHF50.71

Buy

―

Reiterated

09/29/25

Cantor Fitzgerald Sticks to Their Buy Rating for Supernus Pharmaceuticals (SUPN)

Annabel Samimy

Stifel Nicolaus

CHF30.59→CHF34.61

Hold

―

Reiterated

08/06/25

Supernus Pharmaceuticals (SUPN) Gets a Hold from Stifel Nicolaus

Andrew Tsai

Jefferies

CHF32.19

Buy

―

Reiterated

03/12/25

Promising Growth Prospects for Supernus Pharmaceuticals: Buy Rating Driven by Qelbree and Onapgo Market Opportunities

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Supernus Pharmaceuticals

1 Month

xxx

Success Rate

9/13 ratings generated profit

Average Return

+1.43%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +1.43% per trade.

3 Months

xxx

Success Rate

9/13 ratings generated profit

Average Return

+8.77%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +8.77% per trade.

1 Year

Stacy KuTD Cowen

Success Rate

13/14 ratings generated profit

Average Return

+40.86%

reiterated a buy rating 3 days ago

Copying Stacy Ku's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +40.86% per trade.

2 Years

xxx

Success Rate

13/13 ratings generated profit

Average Return

+51.07%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.07% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

S49 Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, S49 has received 11 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. S49 average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

S49 Stock Forecast FAQ

What is CH:S49’s average 12-month price target, according to analysts?

Currently, no data Available

What is CH:S49’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:S49, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

Currently, no data Available

What is Supernus Pharmaceuticals’s share price target?

Currently, no data Available

What do analysts say about Supernus Pharmaceuticals?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of Supernus Pharmaceuticals?

To buy shares of CH:S49, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Supernus Pharmaceuticals (S49) Stock Forecast & Price Target

S49 Analyst Ratings

S49 Stock 12 Month Forecast

S49 Financial Forecast

S49 Earnings Forecast

S49 Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Supernus Pharmaceuticals

S49 Analyst Recommendation Trends

S49 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts